Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Centre approves Bharat Biotech’s Ankleshwar plant for Covaxin production: Mandaviya
In May this year, Bharat Biotech had announced that it plans to produce an additional 200 million doses of Covaxin at its…
NPPA puts cap on trade margin of 42 non-scheduled anti-cancer medicines
The key principles of price regulation by NPPA are the essentiality of drugs, control of prices of formulations and market-based…
Pharma Leadership Forum 2021 – Building a Vision for the Future | 31st August 2021
31st August 2021 | 3:00 PM - 4:45 PM IST | Live Webinar
NIH launches study of third COVID-19 vaccine dose in kidney transplant recipients
The trial will assess antibody response in people who did not respond to two-dose regimen
7th edition of PharmaLytica Expo to take place in Hyderabad on 13th August
The expo will bring together pharma companies, eminent speakers, a knowledge forum and networking opportunities under a hybrid…
Lincoln Pharmaceuticals reports standalone net profit of Rs 17.38 crores in Q1FY22
EBITDA for Q1FY22 was reported at Rs 26.31 crores, a rise of 17.37 per cent as compared to EBITDA of Rs 22.42 crores in Q1FY21
AstraZeneca India’s Q1 net profit declines 45 per cent
Revenue from operations stood at Rs 175.40 crores for the quarter under consideration. It was Rs 193.57 crores for the same period…
Demystifying pharma procurement: Opportunities, challenges and way forward
Express Pharma, in association with SAP India, as part of the Life Sciences Industry Knowledge Exchange Forum, recently hosted a…
BioNTech says repeats of its COVID-19 vaccine better than devising new one, for now
The German biotech firm said that offering a third dose of its established two-shot vaccine remained the best response to concerns…
Philip Morris International acquires OtiTopic
This acquisition is part of PMI's strategic plan to leverage its expertise, scientific know-how and capabilities in inhalation to…